Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors
Sampa Santra(Beth Israel Deaconess Medical Center), Norman L. Letvin(Beth Israel Deaconess Medical Center), Cherie Charbonneau(Beth Israel Deaconess Medical Center), Birgit Korioth-Schmitz(Beth Israel Deaconess Medical Center), Hildegund C.J. Ertl(The Wistar Institute), Gary J. Nabel(National Institutes of Health), Michael S. Seaman(Beth Israel Deaconess Medical Center), Yue Sun(Qingdao Agricultural University), Julie C. Fitzgerald(Children's Hospital of Philadelphia), Sarah J. Ratcliffe(University of Virginia), Giannina Santos(Harvard University), David C. Montefiori(University of Sheffield)
Cited by 49
Related Papers
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
|Nature|2002|1.2k
Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA Vaccination
|Science|2000|885
Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4 <sup>+</sup> T Cells
|Science|1999|872
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
|New England Journal of Medicine|2021|536